— Know what they know.
Not Investment Advice
Also trades as: AYUR.CN (CNQ) · $vol 0M

AYURF OTC

Ayurcann Holdings Corp.
1W: +0.0% 1M: +0.0% 3M: -85.7% YTD: -97.9% 1Y: -99.0% 3Y: -98.9% 5Y: -99.3%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $58411 mcap · 68M float · 0.236% daily turnover · Short 90% of daily vol

Income Trends

Revenue
$31M +23.7% ▲
Gross Profit
$10M +20.0% ▲
Operating Income
-$3M +13.2% ▲
Net Income
-$3M +12.2% ▲
EPS (Diluted)
$-0.01 +41.5% ▲
EBITDA
-$2M +8.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$8M$9M$12M$25M$31M
YoY Growth+0.0%+23.0%+33.1%+101.4%+23.7%
Cost of Revenue$3M$7M$9M$17M$21M
Gross Profit$5M$2M$4M$8M$10M
Gross Margin60.6%23.7%29.5%33.6%32.7%
R&D Expenses$0$0$0$0$0
SG&A Expenses$2M$6M$8M$11M$12M
Operating Expenses$2M$6M$9M$12M$13M
Operating Income$2M-$3M-$5M-$3M-$3M
Operating Margin28.3%-35.5%-42.8%-12.9%-9.1%
Interest Expense$315K$91K$30K$717K$487K
Income Before Tax$57K-$3M-$5M-$4M-$3M
Tax Expense$335K-$335K$97K$0$0
Net Income-$278K-$3M-$5M-$4M-$3M
Net Margin-3.6%-32.9%-42.5%-15.8%-11.2%
EPS (Diluted)$-0.00$-0.03$-0.04$-0.02$-0.01
EBITDA$3M-$3M-$4M-$2M-$2M
Shares Outstanding85M119M150M177M195M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms